Tarsus Pharmaceuticals, Inc. · NASDAQ:TARS

Neervannan Seshadri sold 4,564 Tarsus Pharmaceuticals, Inc. shares (Form 4)

Traded Sep 4, 2026 · Filed Sep 9, 2026

On Sep 4, 2026, Neervannan Seshadri (Chief Operating Officer) sold 4,564 Tarsus Pharmaceuticals, Inc. shares at US$85.00 for US$388K under a trading plan, leaving 78,532 shares. Filed Sep 9, 2026 (Form 4).

Sold
4,564 shares
Price
US$85.00
Value
US$388K
Holding after
78,532 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 4, 2026Common StockSale4,564US$85.0078,532Direct

Source

View original at SEC

Related